Journal
MOLECULES
Volume 28, Issue 23, Pages -Publisher
MDPI
DOI: 10.3390/molecules28237686
Keywords
cannabis; drugs; cannabidiol; tetrahydrocannabinol
Ask authors/readers for more resources
Cannabis plants have been used in medicine for a long time due to their various medicinal properties. However, few cannabis-related drugs have been approved. Research indicates that targeting the endocannabinoid system and other receptors with cannabinoid compounds shows promise for treating multiple medical conditions.
Cannabis plants have been used in medicine since ancient times. They are well known for their anti-diabetic, anti-inflammatory, neuroprotective, anti-cancer, anti-oxidative, anti-microbial, anti-viral, and anti-fungal activities. A growing body of evidence indicates that targeting the endocannabinoid system and various other receptors with cannabinoid compounds holds great promise for addressing multiple medical conditions. There are two distinct avenues in the development of cannabinoid-based drugs. The first involves creating treatments directly based on the components of the cannabis plant. The second involves a singular molecule strategy, in which specific phytocannabinoids or newly discovered cannabinoids with therapeutic promise are pinpointed and synthesized for future pharmaceutical development and validation. Although the therapeutic potential of cannabis is enormous, few cannabis-related approved drugs exist, and this avenue warrants further investigation. With this in mind, we review here the medicinal properties of cannabis, its phytochemicals, approved drugs of natural and synthetic origin, pitfalls on the way to the widespread clinical use of cannabis, and additional applications of cannabis-related products.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available